Does LOSARTAN Cause Myelofibrosis? 13 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Myelofibrosis have been filed in association with LOSARTAN (Losartan Potassium). This represents 0.1% of all adverse event reports for LOSARTAN.
13
Reports of Myelofibrosis with LOSARTAN
0.1%
of all LOSARTAN reports
4
Deaths
6
Hospitalizations
How Dangerous Is Myelofibrosis From LOSARTAN?
Of the 13 reports, 4 (30.8%) resulted in death, 6 (46.2%) required hospitalization, and 5 (38.5%) were considered life-threatening.
Is Myelofibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOSARTAN. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does LOSARTAN Cause?
Drug ineffective (1,640)
Dizziness (1,553)
Headache (1,256)
Dyspnoea (1,185)
Malaise (1,149)
Hypotension (1,139)
Fatigue (1,116)
Acute kidney injury (1,100)
Cough (1,073)
Blood pressure increased (950)
What Other Drugs Cause Myelofibrosis?
RUXOLITINIB (1,316)
ELTROMBOPAG (89)
ROMIPLOSTIM (89)
HYDROXYUREA (88)
IMATINIB (76)
DEFERASIROX (57)
MOMELOTINIB (51)
ASPIRIN (46)
RITUXIMAB (43)
ANAGRELIDE (41)
Which LOSARTAN Alternatives Have Lower Myelofibrosis Risk?
LOSARTAN vs LOSARTAN\LOSARTAN
LOSARTAN vs LOTEPREDNOL ETABONATE
LOSARTAN vs LOTEPREDNOL ETABONATE\TOBRAMYCIN
LOSARTAN vs LOTILANER
LOSARTAN vs LOVASTATIN